Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Manasi Sinha Jaiman, M.D., M.P.H., who was recently appointed Chief Medical Officer at ViaCyte, Inc., a clinical-stage cellular therapy company with...
ViaCyte, Inc., a clinical-stage regenerative medicine company developing novel cell replacement therapies to address diseases with significant unmet...
ViaCyte, Inc., a clinical-stage regenerative medicine company focused on developing novel cell replacement therapies to address diseases with...
ViaCyte, Inc., an innovator in cellular therapy and regenerative medicine, announced today that Michael Yang, President & CEO, will present at the...
Evert Kroon, Ph.D., Vice President of Translation Research at ViaCyte, Inc., an innovator in cellular therapy and regenerative medicine, will...
ViaCyte, Inc., an innovator in cellular therapy and regenerative medicine, announced today that it will present at the Alliance for Regenerative...
ViaCyte, Inc., an innovator in cellular therapy and regenerative medicine, today announced the appointment of Timothy Kieffer, Ph.D., as Chief...
ViaCyte, Inc., an innovator in cellular therapy and regenerative medicine, announced today that it has appointed Jon Wilensky, MD, MBA, FACS, as Head ...
ViaCyte, Inc., a clinical-stage regenerative medicine company focused on developing cell therapies that provide a functional cure for patients with...
ViaCyte, Inc., a clinical-stage regenerative medicine company, today announced the closing of a $45 million financing tranche that brings the total...
Manasi Sinha Jaiman, M.D., M.P.H., Vice President, Clinical Development at ViaCyte, Inc., a clinical-stage regenerative medicine company, will...
ViaCyte, Inc., a clinical stage regenerative medicine company, and W. L. Gore & Associates, Inc. ("Gore"), a leading global materials science company ...
ViaCyte, Inc., a clinical-stage regenerative medicine company, today announced that the first type 1 diabetes (T1D) patients have been implanted in a ...
ViaCyte, Inc., a clinical-stage regenerative medicine company, today announced the appointment of Michael Yang to President and CEO and as a member...
ViaCyte, Inc., a clinical stage regenerative medicine company, today announced the appointment of Manasi Sinha Jaiman, M.D., M.P.H. as Vice...
ViaCyte, Inc., a clinical stage regenerative medicine company, today announced the appointment of Brittany Bradrick as Chief Financial Officer. Ms....
ViaCyte, Inc., a privately held regenerative medicine company, announced today that ViaCyte's President and CEO Paul Laikind, Ph.D. is scheduled to...
ViaCyte, Inc., a privately held regenerative medicine company, today announced the close of an approximately $27 million private financing, part of...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.